Cargando…
Recent advances of CREKA peptide-based nanoplatforms in biomedical applications
Nanomedicine technology is a rapidly developing field of research and application that uses nanoparticles as a platform to facilitate the diagnosis and treatment of diseases. Nanoparticles loaded with drugs and imaging contrast agents have already been used in clinically, but they are essentially pa...
Autores principales: | Zhang, Nannan, Ru, Bin, Hu, Jiaqi, Xu, Langhai, Wan, Quan, Liu, Wenlong, Cai, WenJun, Zhu, Tingli, Ji, Zhongwei, Guo, Ran, Zhang, Lin, Li, Shun, Tong, Xiangmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985238/ https://www.ncbi.nlm.nih.gov/pubmed/36869341 http://dx.doi.org/10.1186/s12951-023-01827-0 |
Ejemplares similares
-
Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide (18)F-iCREKA: Comparison with Its Contrasted Linear Peptide
por: Zhang, Yin, et al.
Publicado: (2019) -
Construction and Evaluation of the Tumor-Targeting, Cell-Penetrating Multifunctional Molecular Probe iCREKA
por: Wang, Li-juan, et al.
Publicado: (2018) -
Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles
por: Huang, Zheyong, et al.
Publicado: (2017) -
Modification of adipose mesenchymal stem cells-derived small extracellular vesicles with fibrin-targeting peptide CREKA for enhanced bone repair
por: Wu, Qi, et al.
Publicado: (2022) -
Recent Advances in Biomedical Applications of Polymeric Nanoplatform Assisted with Two-Photon Absorption Process
por: Ramasundaram, Subramaniyan, et al.
Publicado: (2022)